Medtecs International Valuation

9103 Stock  TWD 6.28  0.08  1.29%   
At this time, the firm appears to be undervalued. Medtecs International secures a last-minute Real Value of NT$7.54 per share. The latest price of the firm is NT$6.28. Our model forecasts the value of Medtecs International from analyzing the firm fundamentals such as Current Valuation of 1.58 B, return on equity of -0.0322, and Profit Margin of (0.06) % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
6.28
Please note that Medtecs International's price fluctuation is not too volatile at this time. Calculation of the real value of Medtecs International is based on 3 months time horizon. Increasing Medtecs International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medtecs stock is determined by what a typical buyer is willing to pay for full or partial control of Medtecs International. Since Medtecs International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medtecs Stock. However, Medtecs International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  6.28 Real  7.54 Hype  6.28 Naive  6.26
The intrinsic value of Medtecs International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medtecs International's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
7.54
Real Value
8.65
Upside
Estimating the potential upside or downside of Medtecs International helps investors to forecast how Medtecs stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtecs International more accurately as focusing exclusively on Medtecs International's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
6.126.386.64
Details
Hype
Prediction
LowEstimatedHigh
5.176.287.39
Details
Naive
Forecast
LowNext ValueHigh
5.156.267.37
Details

Medtecs International Total Value Analysis

Medtecs International is presently anticipated to have takeover price of 1.58 B with market capitalization of 3.9 B, debt of 0, and cash on hands of 8.21 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medtecs International fundamentals before making investing decisions based on enterprise value of the company

Medtecs International Investor Information

The company has Price/Earnings (P/E) ratio of 515.0. Medtecs International last dividend was issued on the 14th of June 2022. The entity had 400:100 split on the 11th of June 2007. Medtecs International is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.

Medtecs International Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medtecs International has an asset utilization ratio of 66.87 percent. This indicates that the Company is making NT$0.67 for each dollar of assets. An increasing asset utilization means that Medtecs International is more efficient with each dollar of assets it utilizes for everyday operations.

Medtecs International Profitability Analysis

The company reported the revenue of 144.16 M. Net Income was 17.34 M with profit before overhead, payroll, taxes, and interest of 43.48 M.

About Medtecs International Valuation

Our relative valuation model uses a comparative analysis of Medtecs International. We calculate exposure to Medtecs International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medtecs International's related companies.
Medtecs International Corporation Limited, an integrated healthcare products and services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups worldwide. The company was founded in 1989 and is headquartered in Taipei City, Taiwan. MEDTECS INTERNATIONAL operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.

8 Steps to conduct Medtecs International's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medtecs International's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medtecs International's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Medtecs International's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Medtecs International's revenue streams: Identify Medtecs International's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Medtecs International's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Medtecs International's growth potential: Evaluate Medtecs International's management, business model, and growth potential.
  • Determine Medtecs International's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medtecs International's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Additional Tools for Medtecs Stock Analysis

When running Medtecs International's price analysis, check to measure Medtecs International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtecs International is operating at the current time. Most of Medtecs International's value examination focuses on studying past and present price action to predict the probability of Medtecs International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtecs International's price. Additionally, you may evaluate how the addition of Medtecs International to your portfolios can decrease your overall portfolio volatility.